Related Experiment Video
Updated: Mar 28, 2026

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
Published on: March 6, 2019
[How to assess clinical practice guidelines with AGREE II: The example of neonatal jaundice]
L Renesme1, A Bedu2, P Tourneux3
1Service de néonatologie, maternité, centre Aliénor-d'Aquitaine, CHU de Bordeaux, place Amélie-Raba-Léon, 33000 Bordeaux, France.
Insights
Neonatal jaundice guidelines vary in quality. The UK
Area of Science:
- Neonatal care
- Clinical practice guidelines
- Bilirubin metabolism
Background:
- Neonatal jaundice affects 50-70% of newborns.
- High bilirubin levels can cause kernicterus.
- Lack of consensus on jaundice management exists globally.
Purpose of the Study:
- To assess the quality of national clinical practice guidelines for neonatal jaundice.
- To compare management strategies across different countries.
Main Methods:
- Systematic literature review of national guidelines.
- Quality assessment using the AGREE II tool by four independent reviewers.
- Analysis of management modalities including screening, treatment, and follow-up.
Main Results:
- Seven national guidelines were identified (South Africa, USA, UK, Canada, Norway, Switzerland, Israel).
- Significant variation in guideline quality was observed based on AGREE II scores.
- Clinical management approaches showed minimal differences across guidelines.
Conclusions:
- The UK's NICE guideline demonstrated the highest quality according to AGREE II.
- The AGREE II tool is recommended for developing future high-quality guidelines.
- A national guideline is needed in France for standardized neonatal jaundice management.
Background:
Neonatal jaundice is a very frequent condition that occurs in approximately 50-70% of term or near-term (>35 GA) babies in the 1st week of life. In some cases, a high bilirubin blood level can lead to kernicterus. There is no consensus for the management of neonatal jaundice and few countries have published national clinical practice guidelines for the management of neonatal jaundice. The aim of this study was to assess the quality of these guidelines.
Methods:
We conducted a systematic review of the literature for national clinical practice guidelines for the management of neonatal jaundice in term or near-term babies. Four independent reviewers assessed the quality of each guideline using the AGREE II evaluation. For each of the clinical practice guidelines, the management modalities were analyzed (screening, treatment, follow-up, etc.).
Results:
Seven national clinical practice guidelines were found (South Africa, USA AAP, UK NICE, Canada, Norway, Switzerland, and Israel). The AGREE II score showed widespread variation regarding the quality of these national guidelines. There was no major difference between the guidelines concerning the clinical management of these babies.
Discussion:
The NICE guideline is the most valuable guideline regarding the AGREE II score. NICE showed that, despite a strong and rigorous methodology, there is no evidenced-based recommended code of practice (RCP). Comparing RCPs, we found no major differences.
Conclusion:
The NICE guideline showed the best quality. The AGREE II instrument should be used as a framework when developing clinical practice guidelines to improve the quality of the future guideline. In France, a national guideline is needed for a more standardized management of neonatal jaundice.
Related Concept Videos
Standards of Care II
Standards of Care I
Guidelines for Nursing Documentation II
Timely documentation is crucial to ensure continuity of care for patients. Any delays in recording or reporting medical information can result in medical errors and even adverse patient outcomes. From medication administration to diagnostic test results, every detail must be accurately and promptly documented to provide the best possible care for patients.
Nephrotic Syndrome II : Assessment and Medical Management
Drug Dosing: Infants and Children
Changes in Skin Color: Clinical Perspectives
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...

